CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore patent oppositions filed by Merck Sharp & Dohme against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Jul 31, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Prevention Of Disulfide Bond Reduction During Recombinant Production Of PolypeptidesGENENTECHDec 1, 2023
Human Antibodies That Bind Lymphocyte Activation Gene-3 (Lag-3) And Uses ThereofE R SQUIBB & SONSApr 27, 2023
Large-Scale Production Of Soluble HyaluronidaseHALOZYMEMay 4, 2022
Tablet Formulation Comprising A Peptide And A Delivery AgentNOVO NORDISKJan 13, 2022
Method Of Treating Cancer Using Immune Checkpoint InhibitorBRISTOL MYERS SQUIBBOct 12, 2021
Immunogenic Compositions Comprising Conjugated Capsular Saccharide Antigens And Uses ThereofPFIZERJun 4, 2021
Compositions And Methods Of Treating Inflammatory And Autoimmune DiseasesAMGENMay 26, 2021
Anti-Factor Xi Monoclonal Antibodies And Methods Of Use ThereofOREGON HEALTH & SCIENCE UNIVERSITYApr 8, 2020
Rna Containing Composition For Treatment Of Tumor DiseasesCUREVACMar 24, 2020
Formulations Which Stabilize And Inhibit Precipitation Of Immunogenic CompositionsWYETHOct 2, 2019

Explore Merck Sharp & Dohme's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jul 31, 2025
Patent NumberGrant DateTitleTotal Oppositions
Nov 13, 2024Pharmaceutical Composition Containing An Anti-Nucleating Agent2
Oct 16, 2024Blood-Based Biomarkers Of Tumor Sensitivity To Pd-1 Antagonists1
Jun 26, 2024Pneumococcal Polysaccharides And Their Use In Immunogenic Polysaccharide-Carrier Protein Conjugates3
May 29, 2024Applicator For Inserting An Implant1
Sep 13, 2023Applicator For Inserting An Implant1
May 4, 2022Combination Of A Pd-1 Antagonist And Eribulin For Treating Cancer4
Nov 3, 2021Immunohistochemical Assay For Detecting Expression Of Programmed Death Ligand 1 (Pd-L1) In Tumor Tissue1
Sep 15, 2021Process For Purifying Insulin And Analogues Thereof1
Sep 1, 2021Combination Of A Pd-1 Antagonist And A Vegfr Inhibitor For Treating Cancer7
Aug 25, 2021Posaconazole Intravenous Solution Formulations Stabilized By Substituted Beta-Cyclodextrin4

Top competitors of Merck Sharp & Dohme

List of top competitors of Merck Sharp & Dohme based on patent oppositions.